… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNAediting technology platform, today announced that Daniel …
… to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today … and ProQR’s RNA oligonucleotide platform and Axiomer RNAediting approaches. Event Details Date/Time: June 22, …
… company dedicated to changing lives through transformative RNA therapies today provided an update that its previously … our primary focus at ProQR remains on our Axiomer ® RNAediting platform,” said Daniel A. de Boer, Founder and …